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Abstract: Our aim was to evaluate the use and impact of the practice walk test on enrolment, 
completion, and clinical functional response to pulmonary rehabilitation (PR) using the 2015 
UK National Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Rehabilitation audit 
data. Patients were assessed according to whether a baseline practice walk test was performed or 
not. Study outcomes included use of the practice walk test, baseline and change in incremental 
shuttle walk test distance (ISWD) or 6-minute walk test distance (6MWD), and enrolment to 
and completion of PR program. Of 7,355 patients, only 1,666 (22.6%) had a baseline practice 
test. At baseline, the practice walk test group walked further as compared to the no practice 
walk test group: ISWD, 17.9 m [95% confidence interval (CI) 8.2–27.5 m] and 6MWD, 34.8 m 
(95% CI 24.7–44.9 m). The practice walk test group were 2.2 times (95% CI 1.8–2.6) more 
likely to enroll and 17% (95% CI 1.03–1.34) more likely to complete PR. Although the change 
in ISWD and 6MWD with PR was lower in the practice walk test group, they walked further at 
discharge assessment. Only 22.6% of the patients in the 2015 National PR audit had a practice 
walk test at assessment. Those who did had better enrolment, completion, and better baseline 
walking distance, from which the prescription is set.
Keywords: pulmonary rehabilitation, COPD, functional performance test, functional exer-
cise test
Introduction
Pulmonary rehabilitation (PR) has become firmly established as a core management 
strategy for patients with COPD.1 In clinical practice, the PR program should include 
outcome assessments to determine patient progress during the program including mea-
sures of functional performance, breathlessness, and health-related quality of life.1
Field exercise tests, such as the 6-minute walk test (6MWT) and incremental 
shuttle walk test (ISWT), are commonly used to assess changes in the functional 
performance among patients with COPD undergoing PR.2–4 Both tests have demon-
strated their validity and reliability and are sensitive to improvement following PR.5 
Importantly, these tests are also the platform for individually prescribing the tailored 
exercise program,6,7 in order to deliver the intensity of training required to gain 
physiological benefit. A recent systematic review determined a learning effect when 
two or more functional exercise tests are conducted5 – a mean improvement of 20 m 
on the second ISWT and 26 m on the second 6MWT. This learning effect is large 
enough to be clinically important when they are used to prescribe exercise and evaluate 
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the improvement due to PR intervention.5 As a result, at 
least one practice functional exercise test at assessment is 
recommended.7
Currently, there is insufficient evidence evaluating the 
effect of the practice walk test at assessment on enrolment 
and completion of PR. The study hypothesized that the 
group having a practice walk test at assessment would have 
a better baseline exercise test with which to base the exercise 
prescription and, thereby, evaluate impact on the clinical 
response to PR.
This study aimed to address, in real-life practice, the use 
and impact of a practice walk test on 1) the baseline exercise 
test; 2) enrolment and completion; and 3) clinical response to 
PR, particularly with regard to the functional assessment.
Methods
Data source
Data from the 2015 National COPD Audit Program’s PR 
workstream, carried out across England and Wales, were 
used for this study.8,9 It includes both the organizational audit 
data and the clinical audit of patients who were referred to 
PR between 12 January and 10 April 2015 from the 210 PR 
programs that participated. Approval from the Caldicott 
Guardian was obtained from each participating unit before 
access to the online audit web tool was granted and, following 
National Confidentiality Advisory Group advice, patients 
enrolled to the audit and provided individual written informed 
consent before their data were uploaded.
Demographics and clinical characteristics
The identified patient demographic and clinical variables 
included the following: age (four categories: ,60, 60 to ,70, 
70 to ,80, and $80 years), gender, Medical Research Coun-
cil (MRC) dyspnea score, smoking status (current, ex, never, 
or not recorded), forced expiratory volume in 1 second (FEV
1
) 
percent predicted, selected comorbidities [atrial fibrillation 
(AF), diabetes (DM), ischemic heart disease (IHD), and left 
ventricular failure (LVF)], whether long-term oxygen therapy 
was used, the functional exercise tests (6MWT and ISWT), 
enrolment to PR and completion of PR (as reported by the 
PR team), proportion of sessions attended out of sessions 
scheduled and then categorized as (#50%, 51%–75%, and 
.75%), and health status measures (St George’s Respiratory 
Questionnaire, and the COPD Assessment Test).
The type of PR (whether cohort, rolling, or other) was 
recorded in two ways: in the analyses at assessment, the type 
of PR for that program was used from organizational data, 
as some individuals who did not enroll would not have this 
data; therefore, for everyone, it was decided that organizational 
data would be used. For those who enrolled, the type of PR 
was recorded as the actual PR program the patient underwent 
(from clinical data). Patients were divided into two groups 
depending on whether they have had a practice walk test at the 
assessment (“Practice test” versus “No practice test”). (Further 
information on the audit can be found in Appendix 1).
Data were described in terms of proportion and mean 
(standard deviation [SD]) as appropriate. Logistic regression 
was used to examine the practice test effect on enrolment, 
starting, and completion of PR between those who had the 
practice test at assessment versus those with no practice tests. 
Potential confounders that changed the relation between 
practice test and enrolment, starting, and completion of PR by 
more than 10% were entered into a final multivariate model 
to calculate the adjusted odds ratios (aOR). Linear regres-
sion was used to further explore the relationship between the 
practice test and ISWD and 6MWD with β regression coef-
ficients and their 95% confidence intervals (CI). All statistical 
analysis was performed using the Stata version 13 software 
(StataCorp LP, College Station, TX, USA).
Results
Demographic and clinical differences
The audit collected data from 7,413 patients; 58 of these 
patients had no record of whether they had a practice test 
at assessment and were thus excluded; 7,355 patients were 
included; 1,666 (22.6%) had a recorded “Practice test” com-
pared to 5,689 (77.3%) with “No practice test.” Demographic 
and clinical characteristics between the two groups are listed 
in Table 1. The significant differences were that the group 
who performed a practice test at assessment were more likely 
to be male and have severe airflow obstruction. Those who 
performed a practice test at assessment were more likely to 
be referred to the PR program which, in the organizational 
data, stated they offered both the cohort and rolling type of 
PR program.
IsWT and 6MWT at baseline
Among 3,812 patients who had ISWT and 2,835 patients 
with 6MWT at assessment, both the ISWD and 6MWD at 
baseline were significantly greater in the practice test group 
compared to the no practice test group. After adjusting for 
age, gender, and type of PR program, linear regression dem-
onstrated that the difference between the two groups was 
maintained (ISWD; β coefficient 17.9 m; 95% CI 8.2–27.5; 
P,0.0001) (6MWD; β coefficient 34.8 m; 95% CI 24.7–44.9; 
P,0.0001).
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enrolment and commencement of 
Pr program
Of the 7,355 patients, 6,269 (85.2%) patients were enrolled 
and subsequently commenced the PR program; 1,518 (91.1%) 
had a practice test and 4,751 (83.5%) did not (Table 2). Of 
those patients who started PR, patients with a practice test 
were more likely to be male and have more severe airflow 
obstruction. In addition, patients were more likely to actu-
ally enroll onto a cohort type of PR program (clinical audit 
data). After adjusting for age, gender, and type of PR, logistic 
regression revealed that those patients with a practice test 
were twice as likely to enroll for PR than those with no 
practice test (aOR 2.2; 95% CI 1.8–2.6). Sensitivity analyses 
in those who did an ISWT and then those who did a 6MWT 
separately were conducted, and included the baseline distance 
to see if this modified the relationship, which it did not.
Completion of Pr program
Of the 6,269 patients who were enrolled, 4,426 (70.6%) 
patients completed the PR program; there were 1,117 (73.5%) 
patients who had a practice test compared to 4,751 (69.6%) 
patients who did not (Table 2). After adjusting for age, gen-
der, and type of PR program, the practice test group were 
17% more likely to complete the PR program (aOR 1.17; 95% 
CI 1.03–1.34). Furthermore, practice test patients attended 
more scheduled PR sessions (P=0.021).
Change in IsWD and 6MWD with Pr
In total, 2,251 patients had both a baseline and discharge 
assessment for ISWT, and 1,662 patients had both assess-
ments for 6MWT. Overall, the mean improvement in ISWD 
was 63 m (95% CI 60.3–66.8 m) and for 6MWD it was 59 m 
(95% CI 54.6–63.7 m). The MCID was achieved in 57% of 
patients for ISWD and in 70% for 6MWD.5,7,10
The change in the distance recorded was lower for 
both tests in the group who had undergone the practice test 
(Table 3). After adjusting for age, gender, and baseline 
Table 1 Demographic and clinical characteristics of patients 
according to whether they had a practice test at baseline 
assessment (n=7,355)
Practice test
n=1,666 n (%)
No practice test
n=5,689 n (%)
P-value 
age category (years)
,60 266 (15.9) 969 (17.0) 0.307
60–,70 593 (35.5) 2,087 (36.6)
70–,80 599 (35.9) 2,000 (35.1)
$80 208 (12.4) 632 (11.1)
Missing 0 1
gender
Male (%) 961 (57.6) 2,952 (51.8) ,0.0001
Female (%) 705 (42.3) 2,737 (48.1)
FeV1% predicted n=1,151 n=3,395 0.003
Mean (sD) 53.1 (19.1) 55.1 (19.9)
gOlD 1 102 (8.8) 383 (11.2) 0.002
gOlD 2 504 (43.7) 1,568 (46.1)
gOlD 3 421 (36.5) 1,122 (33.0)
gOlD 4 124 (10.7) 322 (9.4)
not recorded 515 2,294 
smoking status
never 95 (5.8) 348 (6.2) 0.184
ex-smoker 1,201 (73.3) 3,946 (71.0)
Current smokers 341 (20.8) 1,261 (22.7)
not recorded 29 134 
MrC baseline
MrC 1 & 2 302 (18.8) 886 (17.1) 0.243
MrC 3 609 (38.0) 2,029 (39.1)
MrC 4 533 (33.3) 1,780 (34.3)
MrC 5 155 (6.6) 485 (9.3)
not recorded 67 509 
Comorbidities 
aF 120 (7.2) 358 (6.2) 0.185
DM 232 (13.9) 749 (13.1) 0.422
IhD 180 (10.8) 648 (11.3) 0.505
lVF 42 (2.5) 147 (2.5) 0.886
O2 use 
long-term oxygen 66 (3.9) 227 (3.9) 0.958
Type of Pr offered at that program (organizational audit)
rolling only 508 (30.4) 2,548 (44.7) ,0.0001
Cohort only 582 (34.9) 1,929 (33.9)
Both types 519 (31.1) 1,171 (20.5)
Only other 57 (3.4) 41 (0.7)
exercise test at baseline assessment 
IsWD n=1,004 n=2,808
Mean (sD) 214.1 (134.4) 193.1 (133.3) ,0.0001
6MWD n=668 n=2,167
Mean (sD) 272.4 (114.7) 240.1 (114.1) ,0.0001
enrolment n (%) 1,519 (91.1) 4,762 (83.7) ,0.0001
Commenced Pr n (%) 1,518 (91.1) 4,751 (83.5) ,0.0001
Abbreviations: FeV1, forced expiratory volume in 1 second; sD, standard deviation; 
gOlD, global initiative for obstructive lung disease; MrC, Medical research Council 
Dyspnoea Score; AF, atrial fibrillation; DM, diabetes mellitus; IHD, ischemic heart 
disease; lVF, left ventricular failure; O2, oxygen; Pr, pulmonary rehabilitation; 
IsWD, incremental shuttle walked distance; 6MWD, 6-minute walk distance. 
Table 2 Completion and number of sessions attended of 
pulmonary rehabilitation among patients who started pulmonary 
rehabilitation (n=6,269)
Practice test 
N=1,518 n (%)
No practice test 
n=4,751 n (%)
P-value 
Completed Pr n (%) 1,117 (73.5) 3,309 (69.6) 0.003
Type of Pr that patient underwent (clinical audit) 
rolling 741 (48.8) 2,603 (54.7) 0.0002
Cohort 731 (48.1) 2,001 (42.1)
Other 46 (3.0) 147 (3.0)
Proportion of session attended out of those scheduled
#50% 290 (19.1) 1,111 (23.3) 0.021
51%–75% 236 (15.5) 643 (13.5)
.75% 992 (65.3) 2,997 (63.1)
Abbreviations: Pr, pulmonary rehabilitation; IsWD, incremental shuttle walked 
distance; 6MWD, 6-minute walk distance.
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exercise tests, the practice test patients improved by 12.3 m 
less (ISWD) and 8.9 m less (6MWD) than the no practice 
patients (ISWD change, β coefficient -12.3 m, 95% CI -19.5 
to -5.1, P=0.001; 6MWD change, β coefficient -8.9 m, 
95% CI -19 to 1.4, P=0.09). Patients who had the practice 
test were 41% more likely to improve on their MRC score 
(after adjusting for age and gender, aOR 1.41; 95% CI 
1.21–1.65), whereas there was no difference with regard to 
change in health status.
Discussion
Only 22.6% of the 7,355 patients in the 2015 National 
COPD PR audit had a practice walk test at baseline, despite 
recommendations that a practice test is required in such 
circumstances.7 Not only was the distance of the baseline 
exercise test greater in the group who underwent a practice 
walk test, but also were both enrolment and completion rates 
in this group. Although the change in recorded exercise per-
formance was not greater in the patients with a practice test, 
they performed better at discharge assessment and were more 
likely to have an improvement in their dyspnea score.
The 2015 National COPD PR audit offers an opportunity 
to assess the role of the practice test in a large cohort of 
subjects within the UK who are undergoing PR.8 There is a 
strong recommendation for conducting at least one practice 
test prior to the formal assessment; yet, this was not system-
atically done in the 2015 audit.5,7 In 2000, a survey of 75 PR 
centers across Canada and the USA had reported a similar 
finding – that 80% of PR centers performed only one walk 
test.11 A more recent survey in Australia, reported in 2011, 
suggested a marginally better result – that 39% of 161 PR 
programs performed two tests.12 However, the finding of 
both surveys and our study was underwhelming. There are 
a number of reasons for a center to choose to do or not do a 
practice test, and these are likely to be center-based decisions 
and may reflect educational, resource, or time constraints.
Studies have previously demonstrated that factors such 
as learning effect and motivation influence the exercise 
walking distance.5,13,14 Improvements after a repeated test 
have not only been seen among patients with chronic respi-
ratory disease,5 but also in healthy adults,15 and in patients 
with other medical conditions.16 The marked difference in 
the current study in baseline functional tests between the 
two groups is likely a result of the learning effect after the 
practice test. Unfortunately, the practice test distance was not 
recorded alongside the formal distance in order to ascertain 
the learning effect specifically.
Pulmonary rehabilitation programs prescribe exercise 
training based on the initial exercise assessment outcome. 
The lack of a practice test prior to the formal assessment 
of an exercise test will likely under-represent the distance, 
which then may lead to underestimating the training intensity 
and, thus, the patient’s true training potential.7,17 This study 
shows an association between the functional exercise tests’ 
distances at baseline and discharge and the practice test. One 
possible explanation for the greater change in the exercise 
tests in patients who did not perform a practice test was the 
incorporation of a learning effect into the overall change from 
baseline to post visit. It is possible to speculate, therefore, 
that, if this was removed from the overall PR gain, there was 
less impact of PR in the group without a practice test given 
that the difference at baseline was greater than the mean 
change. Furthermore, more patients improved their breath-
lessness score in the group who performed the practice test, 
suggesting better clinical improvement. Although improve-
ments in dyspnea with PR are well recognized regardless 
of the patients’ initial degree of dyspnea,1,18 this interesting 
finding associated with the practice test perhaps relates to 
the improved exercise prescription received.
Moreover, these data highlight the apparent impact of 
the practice walk test on enrolment and completion of PR. 
Factors that affect enrolment and completion of PR programs 
Table 3 Change in functional exercise tests stratified by practice test at assessment for patients who had both a baseline and discharge 
assessment test recorded
Mean (SD) ISWD 6MWD
Practice test 
n=626
No practice test 
n=1,625
Practice test 
n=414
No practice test 
n=1,248
at baseline 221 m (136) 202 m (129) 287 m (110) 258 m (112)
at discharge 275 m (156) 269 m (151) 337 m (111) 320 m (140)
Change 54 m (79) 67 m (78) 49 m (57) 62 m (103)
Difference of the change in functional exercise tests between the two groups
Unadjusted β coefficient (95% CI) -12.9 m (-5.6 to -20.2) -12.5 m (-4.5 to -20.5)
adjusted β coefficient (95% CI)* -12.3 m (-19.5 to -5.1) -8.9 m (-19 to 1.4)
Note: *After adjusting for age, gender, and baseline exercise distance.
Abbreviations: m, meters; IsWD, incremental shuttle walked distance; 6MWD, 6-minute walk distance.
International Journal of COPD 2017:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2685
Practice walk test in pulmonary rehabilitation programs
are widely recognized and include transportation to the 
PR center, social deprivation, smoking status, and level of 
comorbidities.19–23 The findings here demonstrate that the 
practice walk test was also associated with enrolment and 
completion of PR.
strengths and limitations
The strength of this study was that the audit is comprehen-
sive, large, and representative of the UK, with over 7,000 
individuals attending an assessment for PR. However, dif-
ferences exist among PR programs across countries. There 
might be other quality or process factors influencing both the 
conduct of the practice walk test and the outcomes including 
staffing or other resources that are not directly possible to 
analyze here. In addition, the actual distance value of the 
practice walk test was not recorded, and we know very little 
about practicalities such as the timing of the procedure or 
the reasons why a practice was not performed.
Conclusion
Only 22.6% of patients being assessed for PR had a prac-
tice test prior to their exercise assessment. The practice test 
impacts on clinical outcomes and, thus, is not a trivial issue. 
Although this may be a measure of broader service quality, 
its utility in reliably setting an exercise prescription cannot 
be ignored. There are important clinical implications of this 
work for the conduct of PR. This work robustly demonstrates 
the role of the practice walk test in the baseline assessment 
of PR to maximize the benefits of the program. Following 
awareness of the impact of the practice walk test, there will 
be educational, practical, and resource issues that need con-
sideration to implement this across the programs. Finally, 
given that PR is central to the management of COPD, the 
technical standards for the performance of exercise tests 
need to be understood and implemented by rehabilitation 
practitioners in the field.
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